Nirupama Sabnis

1.7k total citations
37 papers, 1.2k citations indexed

About

Nirupama Sabnis is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Nirupama Sabnis has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Cancer Research and 10 papers in Biomaterials. Recurrent topics in Nirupama Sabnis's work include Nanoparticle-Based Drug Delivery (10 papers), Cancer, Lipids, and Metabolism (10 papers) and RNA Interference and Gene Delivery (4 papers). Nirupama Sabnis is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Cancer, Lipids, and Metabolism (10 papers) and RNA Interference and Gene Delivery (4 papers). Nirupama Sabnis collaborates with scholars based in United States, China and France. Nirupama Sabnis's co-authors include Andras G. Lacko, Walter J. McConathy, Tony Romeo, Huanbiao Mo, Honghui Yang, Sangram Raut, B. Nagarajan, Linda Mooberry, Zygmunt Gryczyński and Ignacy Gryczyński and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Nirupama Sabnis

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nirupama Sabnis United States 19 554 392 225 220 208 37 1.2k
Giovanna Esposito Italy 20 633 1.1× 188 0.5× 120 0.5× 184 0.8× 215 1.0× 43 1.5k
Marta Truffi Italy 24 704 1.3× 220 0.6× 154 0.7× 405 1.8× 394 1.9× 69 1.7k
Kira Foygel United States 21 704 1.3× 258 0.7× 90 0.4× 178 0.8× 582 2.8× 28 1.4k
Funan Liu China 20 613 1.1× 158 0.4× 105 0.5× 170 0.8× 265 1.3× 54 1.3k
Lavinia Morosi Italy 22 876 1.6× 327 0.8× 141 0.6× 175 0.8× 171 0.8× 47 1.5k
Mariana Varna France 21 589 1.1× 361 0.9× 77 0.3× 187 0.8× 240 1.2× 40 1.5k
Xiaojia Chen China 18 739 1.3× 390 1.0× 61 0.3× 117 0.5× 147 0.7× 68 1.2k
Shuang Cai China 23 815 1.5× 240 0.6× 82 0.4× 370 1.7× 335 1.6× 60 1.8k
Sergey A. Samsonov Poland 28 1.5k 2.7× 233 0.6× 66 0.3× 132 0.6× 90 0.4× 124 2.2k

Countries citing papers authored by Nirupama Sabnis

Since Specialization
Citations

This map shows the geographic impact of Nirupama Sabnis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirupama Sabnis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirupama Sabnis more than expected).

Fields of papers citing papers by Nirupama Sabnis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirupama Sabnis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirupama Sabnis. The network helps show where Nirupama Sabnis may publish in the future.

Co-authorship network of co-authors of Nirupama Sabnis

This figure shows the co-authorship network connecting the top 25 collaborators of Nirupama Sabnis. A scholar is included among the top collaborators of Nirupama Sabnis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirupama Sabnis. Nirupama Sabnis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabnis, Nirupama, Rafał Fudala, Andras G. Lacko, et al.. (2025). Fluorescence Resonance Energy Transfer for Drug Loading Assessment in Reconstituted High-Density Lipoprotein Nanoparticles. International Journal of Molecular Sciences. 26(7). 3276–3276. 1 indexed citations
2.
Sabnis, Nirupama, et al.. (2025). Biodistribution of Reconstituted High-Density Lipoprotein Nanoparticles for Targeted Delivery to Retinal Ganglion Cells. Journal of Ocular Pharmacology and Therapeutics. 41(5). 281–289.
3.
Sabnis, Nirupama, Zygmunt Gryczyński, Rafał Fudala, et al.. (2024). Photophysical Characterization and In Vitro Evaluation of α-Mangostin-Loaded HDL Mimetic Nano-Complex in LN-229 Glioblastoma Spheroid Model. International Journal of Molecular Sciences. 25(13). 7378–7378. 3 indexed citations
4.
Lacko, Andras G., et al.. (2024). Reconstituted HDL ameliorated renal injury of diabetic kidney disease in mice. Physiological Reports. 12(15). e16179–e16179. 3 indexed citations
5.
Tripathi, Amit Kumar, et al.. (2023). Cabazitaxel-Loaded Nanoparticles Reduce the Invasiveness in Metastatic Prostate Cancer Cells: Beyond the Classical Taxane Function. Pharmaceutics. 15(2). 662–662. 5 indexed citations
8.
Lacko, Andras G., et al.. (2023). Prospects for developing lipoprotein-based drug transporters for therapeutic applications.. Medical Research Archives. 11(1). 3 indexed citations
9.
Raut, Sangram, B. Nagarajan, Nirupama Sabnis, et al.. (2020). Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence. Journal of Pharmacology and Experimental Therapeutics. 373(1). 113–121. 6 indexed citations
10.
Sabnis, Nirupama, et al.. (2020). Lipoproteins and the Tumor Microenvironment. Advances in experimental medicine and biology. 1272. 93–116. 2 indexed citations
11.
Raut, Sangram, et al.. (2018). Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy. Frontiers in Pharmacology. 9. 1154–1154. 48 indexed citations
12.
Sabnis, Nirupama, et al.. (2017). Ultrasound-Stimulated Drug Delivery Using Therapeutic Reconstituted High-Density Lipoprotein Nanoparticles. Nanotheranostics. 1(4). 440–449. 21 indexed citations
13.
Johnson, Rebecca H., et al.. (2017). SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer. Breast Cancer Targets and Therapy. Volume 9. 383–392. 13 indexed citations
14.
Mooberry, Linda, et al.. (2016). Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging. Frontiers in Pharmacology. 7. 466–466. 106 indexed citations
15.
Lacko, Andras G., Nirupama Sabnis, B. Nagarajan, & Walter J. McConathy. (2015). HDL as a drug and nucleic acid delivery vehicle. Frontiers in Pharmacology. 6. 247–247. 60 indexed citations
16.
Sabnis, Nirupama, W. Paul Bowman, & Andras G. Lacko. (2015). Lipoprotein based drug delivery: Potential for pediatric cancer applications. 4(2). 172–172. 3 indexed citations
17.
Basha, Riyaz, Nirupama Sabnis, Kenneth Heym, W. Paul Bowman, & Andras G. Lacko. (2014). Targeted Nanoparticles for Pediatric Leukemia Therapy. Frontiers in Oncology. 4. 101–101. 19 indexed citations
18.
Sabnis, Nirupama, et al.. (2013). Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma. Frontiers in Pediatrics. 1. 6–6. 30 indexed citations
19.
Kulkarni, G.R., Nirupama Sabnis, Kolari S. Bhat, & Ben G. Harris. (2005). CLONING AND NUCLEOTIDE SEQUENCE OF A FULL-LENGTH cDNA ENCODING ASCARIS SUUM PHOSPHOFRUCTOKINASE. Journal of Parasitology. 91(3). 585–590. 2 indexed citations
20.
Sabnis, Nirupama, Honghui Yang, & Tony Romeo. (1995). Pleiotropic Regulation of Central Carbohydrate Metabolism in Escherichia coli via the Gene csrA. Journal of Biological Chemistry. 270(49). 29096–29104. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026